75 related articles for article (PubMed ID: 9638515)
1. Vascular dopamine-I receptors and atherosclerosis.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
J Atheroscler Thromb; 1997; 4(2):59-64. PubMed ID: 9638515
[TBL] [Abstract][Full Text] [Related]
2. Anti-atherosclerotic action of vascular D1 receptors.
Yasunari K; Kohno M; Kano H; Hanehira T; Minami M; Yoshikawa J
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S36-40. PubMed ID: 10386252
[TBL] [Abstract][Full Text] [Related]
3. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Yasunari K; Kohno M; Hasuma T; Horio T; Kano H; Yokokawa K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3164-73. PubMed ID: 9409307
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Hypertension; 1997 Jan; 29(1 Pt 2):350-5. PubMed ID: 9039126
[TBL] [Abstract][Full Text] [Related]
5. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors.
Yasunari K; Kohno M; Kano H; Minami M; Yoshikawa J
Circulation; 2000 May; 101(19):2302-8. PubMed ID: 10811599
[TBL] [Abstract][Full Text] [Related]
6. Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors.
Yasunari K; Maeda K; Nakamura M; Yoshikawa J
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S33-8. PubMed ID: 12688394
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.
Zhou Y; Shi W; Luo H; Yue R; Wang Z; Wang W; Liu L; Wang WE; Wang H; Zeng C
Hypertens Res; 2015 Dec; 38(12):807-12. PubMed ID: 26178154
[TBL] [Abstract][Full Text] [Related]
9. 2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle.
Xu XL; Huang YJ; Wang YQ; Chen XF; Zhang W
Clin Exp Pharmacol Physiol; 2011 May; 38(5):307-13. PubMed ID: 21348889
[TBL] [Abstract][Full Text] [Related]
10. Ligustrazine attenuates the platelet-derived growth factor-BB-induced proliferation and migration of vascular smooth muscle cells by interrupting extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways.
Yu L; Huang X; Huang K; Gui C; Huang Q; Wei B
Mol Med Rep; 2015 Jul; 12(1):705-11. PubMed ID: 25738255
[TBL] [Abstract][Full Text] [Related]
11. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells.
Sivamurthy N; Stone DH; Logerfo FW; Quist WC
J Vasc Surg; 2001 Oct; 34(4):716-23. PubMed ID: 11668329
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of intravenous anesthetics on PDGF-BB-induced vascular smooth muscle cell migration.
Iida M; Tanabe K; Kozawa O; Iida H
Cell Physiol Biochem; 2014; 33(6):1827-37. PubMed ID: 24969327
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
17. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.
Kannemeier C; Al-Fakhri N; Preissner KT; Kanse SM
FASEB J; 2004 Apr; 18(6):728-30. PubMed ID: 14977886
[TBL] [Abstract][Full Text] [Related]
18. Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades.
Gomes P; Soares-da-Silva P
Eur J Pharmacol; 2004 Mar; 488(1-3):51-9. PubMed ID: 15044035
[TBL] [Abstract][Full Text] [Related]
19. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.
Zeng C; Han Y; Huang H; Yu C; Ren H; Shi W; He D; Huang L; Yang C; Wang X; Zhou L; Jose PA
J Hypertens; 2009 May; 27(5):1033-41. PubMed ID: 19293728
[TBL] [Abstract][Full Text] [Related]
20. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
